Search research articles
Contact Us
Filters
Showing results (101-110 of 278) with videos related to
Page
of 28
Sort By:
Genes, Chromosomes & Cancer
|
June 26, 2023
Comprehensive molecular profile of primary cutaneous epithelioid rhabdomyosarcoma: A tumor genomically and molecularly related to malignant melanoma
Saba Shafi, Manan Shah, Dan Jones, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 17, 2005
Differential expression of WT1 gene product in non-Hodgkin lymphomas
Elias Drakos, George Z Rassidakis, Panagiota Tsioli, et al.
American Journal of Clinical Pathology
|
August 30, 2006
Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia
Pei Lin, Dan Jones, L Jeffrey Medeiros, et al.
Human Pathology
|
October 17, 2003
Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman's disease
Xiaoping Sun, Kong-Chao Chang, Lynne V Abruzzo, et al.
Cancer
|
April 22, 2011
Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
Elias Jabbour, Susan Branford, Giuseppe Saglio, et al.
Radiation Protection Dosimetry
|
May 29, 2007
Progress in dosimetry of neutrons and light nuclei
Jan Blomgren, Lennart Lindborg, Natalia Golnik, et al.
Archives of Pathology & Laboratory Medicine
|
November 9, 2006
Lymphomas involving the pleura: a clinicopathologic study of 34 cases diagnosed by pleural biopsy
Francisco Vega, Anthony Padula, Jose R Valbuena, et al.
Blood
|
July 3, 2010
Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects
Dan Jones, Su S Chen, Elias Jabbour, et al.
Blood
|
September 23, 2006
MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation
Francis J Giles, Jorge Cortes, Dan Jones, et al.
Rapid Communications in Mass Spectrometry : RCM
|
June 5, 2007
Laser desorption/ionization mass spectrometry on porous silicon for metabolome analyses: influence of surface oxidation
Seetharaman Vaidyanathan, Dan Jones, Joanne Ellis, et al.
Page
of 28
Search research articles
Search
Showing results (101-110 of 278) with videos related to
Sort By:
Page
of 28
Genes, Chromosomes & Cancer
|
June 26, 2023
Comprehensive molecular profile of primary cutaneous epithelioid rhabdomyosarcoma: A tumor genomically and molecularly related to malignant melanoma
Saba Shafi, Manan Shah, Dan Jones, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 17, 2005
Differential expression of WT1 gene product in non-Hodgkin lymphomas
Elias Drakos, George Z Rassidakis, Panagiota Tsioli, et al.
American Journal of Clinical Pathology
|
August 30, 2006
Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia
Pei Lin, Dan Jones, L Jeffrey Medeiros, et al.
Human Pathology
|
October 17, 2003
Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman's disease
Xiaoping Sun, Kong-Chao Chang, Lynne V Abruzzo, et al.
Cancer
|
April 22, 2011
Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
Elias Jabbour, Susan Branford, Giuseppe Saglio, et al.
Radiation Protection Dosimetry
|
May 29, 2007
Progress in dosimetry of neutrons and light nuclei
Jan Blomgren, Lennart Lindborg, Natalia Golnik, et al.
Archives of Pathology & Laboratory Medicine
|
November 9, 2006
Lymphomas involving the pleura: a clinicopathologic study of 34 cases diagnosed by pleural biopsy
Francisco Vega, Anthony Padula, Jose R Valbuena, et al.
Blood
|
July 3, 2010
Uncommon BCR-ABL kinase domain mutations in kinase inhibitor-resistant chronic myelogenous leukemia and Ph+ acute lymphoblastic leukemia show high rates of regression, suggesting weak selective effects
Dan Jones, Su S Chen, Elias Jabbour, et al.
Blood
|
September 23, 2006
MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation
Francis J Giles, Jorge Cortes, Dan Jones, et al.
Rapid Communications in Mass Spectrometry : RCM
|
June 5, 2007
Laser desorption/ionization mass spectrometry on porous silicon for metabolome analyses: influence of surface oxidation
Seetharaman Vaidyanathan, Dan Jones, Joanne Ellis, et al.
Page
of 28